Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and treat diseases, including cancer. Differences in DNA, RNA, and protein can be identified in individual tissue samples, and even in individual cells.
The massive data sets generated from this research have driven advances in data science and are used to inform additional studies and clinical practice. Standard treatment for some cancers now include genotyping or molecular imaging in living patients.
This is an extraordinarily exciting time to be involved in precision medicine for cancer. This new whitepaper from Corning reviews some of the topics and trends in this emerging research area.
Download now to understand:
- 3D cultures: Spheroids and organoids
- Organoids in cancer research
- Tumour microenvironments
- Organ-on-a-chip and body-on-a-chip
- 3D bioprinting
